Control of selective estrogen receptor modulators
US6653297B1 · kind B1 · utility
10Cited by
3References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 13, 1998 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Apr 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The treatment of an estrogen sensitive condition by the administration of a selective estrogen receptor modulator is improved by additionally administering a progestationally active compound to the recipient. The additional agent can express both progestational and androgenic activity or an androgenically active material can be employed, if desired. Additionally, clomiphene in an array of isomeric ratios (EN:ZU) can be used alone for prevention of osteoporosis, maintenance of a healthful blood lipid profile, and prevention of breast tumors, or to sustain amenorrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.